Ignite Creation Date:
2024-05-06 @ 6:15 PM
Last Modification Date:
2024-10-26 @ 2:44 PM
Study NCT ID:
NCT05598814
Status:
RECRUITING
Last Update Posted:
2023-11-30
First Post:
2022-10-25
Brief Title:
Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks
Sponsor:
Vibeke Backer
Organization:
Rigshospitalet Denmark
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-25
First Submit QC Date:
October 25 2022
Study First Post Date:
2022-10-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-27
Last Update Post Date:
2023-11-30
Last Update Post Date Type:
ACTUAL